Here are Monday’s biggest calls on Wall Street: Morgan Stanley reiterates Live Nation as overweight Morgan Stanley said shares of the entertainment concert company are compelling. ” LYV is an attractive play on strong (and macro resilient) consumer demand for live concerts with a now even more compelling risk/ reward. Reiterate OW.” Cantor Fitzgerald reiterates Nvidia as overweight Cantor Fitzgerald said the stock is still a top pick at the firm. “No change to 12-month TOP PICKS list (remain NVDA, WDC, NXPI, ASML, and AMAT) but outperformers near-term from here likely led by NVDA , MU, AVGO, and MRVL.” TD Cowen reiterates Apple as buy TD Cowen raised its price target to $250 per share from $220 ahead of earnings later this week. “We expect AAPL to report in-line results and outlook as NT [near term] headwinds could include modest China market share loss to Huawei devices, macro impact on consumer demand and FX.” Wells Fargo upgrades Booz Allen Hamilton to overweight from equal weight Wells Fargo said it is getting bullish on shares of the management consulting service company. “We upgrade to Overweight, as we think issues driving the Q1 EBITDA shortfall are temporary and mostly behind us. BAH is one of the highest return companies in A & D, trading at a discount to historical relative valuation after a rare operating miss.” Guggenheim upgrades Akamai to buy from neutral Guggenheim said shares of the cloud computing networking company have more room to run. “We are upgrading AKAM to Buy from Neutral and are introducing a price target of $128, as we believe the company can leverage its leadership CDN position to deliver Security and Cloud solutions that will not only provide incremental value in themselves, but will also increase the value of AKAM’s leading CDN [content delivery networking] business.” Piper Sandler downgrades Charles Schwab to neutral from overweight Piper Sandler said it sees “strategic shift uncertainty” for Schwab. “Downgrading shares of Charles Schwab (SCHW) from Overweight to Neutral.” RBC upgrades Sarepta Therapeutics to outperform from sector perform RBC said in its upgrade of Sarepta Therapeutics that shares of the biotech company are compelling. “We see an opportunity to buy the stock near pre-label expansion levels ahead of a likely major launch.” Deutsche Bank upgrades Northrop Grumman to buy from hold Deutsche Bank upgraded the stock following earnings last week. “We are upgrading NOC to Buy (from Hold) with an updated target price of $575 ($474 prior).” JPMorgan upgrades Olin to overweight from neutral JPMorgan said it is bullish on shares of the chemical company. ” Olin’s efforts to stabilize chlorine and caustic prices in the US by running at low rates of capacity utilization from the fourth quarter of 2023 through the first quarter of 2024 have been generally successful.” Mizuho reiterates Uber and Booking Holdings as outperform Mizuho said the two stocks are top picks ahead of earnings. “Resilient Demand & Low Expectations Create Positive Setup; UBER and BKNG Top Picks.” Deutsche Bank upgrades 3M to buy from hold Deutsche Bank said it is bullish on new company management for 3M. “Since Bill Brown’s appointment to the CEO role in mid-March, we have heard nothing but positive anecdotes from colleagues and investors about his legacy at L3Harris.” Bank of America reiterates Apple as buy Bank of America said it is bullish heading into Apple earnings later this week. “We see pent up demand and a meaningful number of older iPhones in the installed base, and the new AI features should help drive an upgrade cycle. Reiterate Buy on benefits from GenAI at Edge with gross margin upside and momentum in Services.” Barclays downgrades Bristol-Myers Squibb to underweight from equal weight Barclays downgraded Bristol-Myers Squibb due to “competitor noise/headwinds.” “After a 25% share price rally despite little movement in underlying post-2025 fundamentals, we move to Underweight – amidst must-have 2H catalysts, competitor noise/headwinds, and risk of unwind after recent rotation.” JPMorgan reiterates Eli Lilly as overweight JPMorgan said the stock is a “core holding” ahead of earnings on Aug. 8. “While we understand not wanting to miss a bounce off the bottom for some of these lower multiple stories, we continue to see LLY, MRK, and ABBV as the core holdings in the space.” Evercore ISI reiterates Amazon as outperform Evercore ISI said it is sticking with its outperform rating on the stock ahead of earnings later this week. “We see a Modest Beat & Bracket quarter as the most likely outcome for AMZN’s Q2 EPS results.” Morgan Stanley names Tesla a top pick Morgan Stanley named the stock a new top pick. “With 40% upside to our $310 target, more managed expectations on autos and powerful emerging drivers of firm value, we make Tesla our new ‘Top Pick’ in US Autos, replacing Ford.” Oppenheimer reiterates Coinbase as outperform Oppenheimer said the crypto company could be a candidate for inclusion into the S & P 500. “We believe 1) increasing regulatory clarity, and 2) digital asset becoming mainstream can increase the chance that COIN will be included in S & P 500.” Raymond James reiterates Microsoft as outperform The firm said it is bullish heading into earnings on Tuesday. “Sentiment has been strongly positive on Microsoft with AI dominating conversations around tech and MSFT enjoying an enviable position at the vanguard of the new technology.” D.A. Davidson upgrades Shyft Group to buy from neutral D.A. Davidson said shares of the auto company are well positioned. “We are upgrading SHYF to BUY (from Neutral) with a new price target of $18 following 2Q:24 results.” Raymond James downgrades Charter to underperform from market perform Raymond James downgraded the cable giant due to rising competition. “We are downgrading shares of Charter (CHTR) to Underperform from Market Perform following 2Q earnings and with competitive pressures expected to get worse in the near term.” HSBC downgrades Arm to reduce from hold HSBC said in its downgrade of Arm that the “AI narrative [is] not enough to sustain re-rating.” “Ahead of 1Q25 results on 31 July, we also see short-term earnings downside risk given a potential slowdown in Android smartphone momentum and a less bullish AI narrative than previously expected.”
